Intriguingly, the Y861C mutation of NLRP3 has been identified in patient with chronic infantile neurologic cutaneous and articular syndrome (CINCA), consistent with the result that the Y861F mutation of NLRP3 indeed exhibits an elevated level of inflammasome activation, compared with wild-type NLRP3. The gene discussed is NLRP3; the disease is CINCA syndrome.